The birth of a male baby was induced at 32 weeks. In utero, the child presented, inter alia, signs of hydrops, hepatosplenomegaly and anaemia. Two in utero transfusions for correction of the anaemia were performed at 28 and 29 weeks, respectively. The baby rapidly presented respiratory distress with mixed acidosis. Three hours after birth, pink urine was excreted. Signs of icterus necessitated phototherapy, after which photosensitivity occurred. Erythrocytes were fluorescent under long-wavelength UV light. The baby died 24 hours after birth, displaying severe acidosis, a diffuse haemorrhagic syndrome, and repeated bradycardia which did not respond to isoprenaline.
Introduction
, . . . . . , , erythropoietic porphyna is characterized by an overGünther's disease, also called congenital erythropoi-production of porphyrins of isomer I series, with etic porphyria (CEP), is a very rare (less than 200 accumulation of these compounds in bone marrow cases reported) type of porphyria (1, 2) . Congenital erythroblasts, teeth and bones (1, 2) . These porphyrins are excreted in excess in urine and faeces (1, 2) . Patients with congenital erythropoietic porphyria show an inability to maintain the normal production of porphyrins of isomer III type, consistent with diminished activity of uroporphyrinogen III synthase 1 ) (or cosynthetase or hydroxymethylbilane hydrolase cyclizing, EC 3.2.1.75) (3) . Congenital erythropoietic porphyria is inherited as a Mendelian autosomal recessive trait (4) . The onset of the majority of cases occurs before the 6th year of life and the main symptoms are cutaneous photosensitivity and haemolysis (5) . Congenital erythropoietic porphyria is very rarely detected in utero or at birth (6, 7, 8) .
Our patient is a male premature neonate. Birth was induced at 32 weeks, because he presented in utero, inter alia, signs of hydrops, hepatosplenomegaly and anaemia. Two in utero transfusions for correction of the anaemia were performed at 28 and 29 weeks, respectively. The patient rapidly presented respiratory distress with mixed acidosis. t Three hours after birth, pink urine was excreted. Signs of icterus necessitated phototherapy, after which marked photosensitivity occurred. Red blood cells and bone marrow erythroblasts were fluorescent (red) under long-wavelength UV light.
The baby died 24 h after birth, displaying severe acidosis, a diffuse haemorrhagic syndrome, and repeated bradycardia which did not respond to isoprenaline (Isuprel®).
This study describes the contribution of biochemical investigations to the diagnosis of this rare type of porphyria, associated with unusual clinical onset. We also report the investigation of porphyrin metabolism in the parents. 
Materials and Methods
Urinary 5-aminolaevulinic acid and porphobilinogen were determined spectrophotometrically after elution from ion-exchange resins (Bio-Rad, Germany), according to Mauzerall & Granick (9 Urinary and faecal porphyrins were determined by high performance liquid chromatography (HPLC) as previously described (9) . Plasma porphyrins were determined by HPLC, using a method derived from that of Longas & Poh-Fiizpairick (10).
Erythrocyte porphyrins were determined by HPLC, using a method derived from that of Scoble et al. (11) .
Isomers I and III in urine, faeces, plasma and erythrocytes were fractionated by HPLC, using a method derived from that of Lim et al. (12) .
Uroporphyrinogen III synthase activity in erythrocytes (both parents) was determined as previously described (8). ) were determined in lymphocytes as previously described (14, 15) . led us to a more detailed investigation of porphyrin metabolism, including the fractionation of isomers I and III, and determination of the enzymes of haem biosynthesis. This study was performed on the patient and his two parents. Tables 1 to 4 present the results of porphyrin determinations in plasma, erythrocytes, urine and faeces.
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In the patient, tetracarboxyporphyrin (almost exclusively isomer I) was strongly increased in erythrocytes, plasma, urine and faeces. Octacarboxyporphyrin (a mixture of isomers I and III) was strongly increased in urine and to a lesser degree in faeces. Heptacarboxyporphyrin (isomer I) was increased in urine, and to a lesser degree in plasma, erythrocytes and faeces. Table 5 shows the results for several enzymes of haem biosynthesis.
Results
Some features of the clinical investigation (emission of pink urine, hirsutism, photosensitivity) and the erythrocyte fluorescence under long-wavelength UV
Discussion
Although one of the rarest of the porphyrias, congenital erythropoietic porphyria was the first of these diseases recorded in the literature, probably because of the severity of its cutaneous symptoms (16) . Congenital erythropoietic porphyria is a very rare disease (less than 200 cases reported in the literature). Higher prevalences reported previously are explained by confusion with early-onset cases of cutaneous hepatic porphyria (17, 18, 19) .
The pattern of porphyrin overproduction in congenital erythropoietic porphyria indicates that the block in the haem synthetic pathway occurs at the level of uroporphyrinogen III synthase (3, (20) (21) (22) (23) (24) (25) . This enzyme catalyses the formation of uroporphyrinogen III from hydroxymethylbilane or from porphobilinogen if porphobilinogen deaminase is present (2) . Patients with congenital erythropoietic porphyria demonstrate an inability to maintain the normal production of series III isomers, consistent with a diminished activity of uroporphyrinogen III synthase (3).
Erythrocyte uroporphyrinogen III synthase activity in both parents of our patient is about 50% of the normal value, which is compatible with an heterozygous state for congenital erythropoietic porphyria (26) .
Although there is a deficiency of uroporphyrinogen III synthase, it does not completely block the synthesis of series III isomer porphyrins (1, 2). Indeed, as stated previously, there is some increase in total porphyrin synthesis, as evidenced by increased concentrations in peripheral blood and urine (1, 2) . In our patient, we observed a large predominance of type-I isomers of tetra; penta-and heptacarboxyporphyrins in all the biological material examined (erythrocytes, plasma, urine and faeces). The octacarTDoxyporphyrins were detected in small amounts in erythrocytes, plasma and faeces, and high quantities were excreted in urine. In all these biological fluids, the ratio of isomer I to isomer III varied from 30 to 50%.
Furthermore, increased concentrations of erythrocyte porphyrins have been found in relatives of congenital erythropoietic porphyria patients, consistent with a partial deficiency of uroporphyrinogen III synthase in heterozygotes (3, (27) (28) (29) . In our study, plasma and erythrocyte porphyrins were within reference range for both parents. The patient showed extremely high concentrations of plasma and erythrocyte coproporphyrin, almost exclusively of the type-I isomer.
Typically, the urinary total porphyrin concentration in congenital erythropoietic porphyria is between 20000 and 90000 nmol/1 (2). This consists mainly of uroporphyrin and heptacarboxylic porphyrin, with 10-20% coproporphyrin (30, 31) . In our patient, urine total porphyrin concentration was about 430000 nmol/1. Coproporphyrin (almost exclusively type-I isomer) is predominant in urine. Both parents have urine porphyrin values within the reference range, but the father excretes predominantly type-I coproporphyrin. It is to be noted that the coproporphyrin in normal urine consists of 70% isomer III and 30% isomer I (32). An increased ratio of coproporphyrin I to coproporphyrin III may be observed in other diseases such as cholestasis and Dubin-Johnson syndrome (33, 34) . Excessive production of intermediate porphyrins, as found by HPLC, also occurs in cutaneous hepatic porphyria, but the pattern of excreted compounds is quite different (1, 2) . Isomeric fractionation shows that more than 80% of the total porphyrin is of series I, although, as stated before, there is also an overall increase in the production and excretion of uroporphyrinogen III (1, 2). Concerning uroporphyrin, isomeric fractionation reveals a mixture of isomers I and III in all samples examined, whereas the typical pattern shows a predominance of type-I isomers (1). The predominance of uroporphyrin I over uroporphyrin III may also be observed in cases of cutaneous hepatic porphyria (35) .
Faecal porphyrins are usually elevated in congenital erythropoietic porphyria, consisting predominantly of coproporphyrin, with a variable, but usually slight increase in protoporphyrin (1, 2) . Uroporphyrin is also normally detectable in the faeces (1, 2). Unlike cutaneous hepatic porphyria, the isocoproporphyrin series of porphyrins is not detected (1, 2) . In our patient, faecal coproporphyrin is strongly increased, together with a mild increase of uroporphyrin, heptaand pentacarboxyporphyrins.
The strong increase of coproporphyrin in all biological samples led us to consider the diagnosis of a coexistent hereditary coproporphyria, an association previously described in a young female patient (36) . This diagnosis was ruled out by the presence of normal values for lymphocyte coproporphyrinogen Oxidase observed in both parents. The presence in all biological samples examined (erythrocytes, plasma, urine, faeces) of high concentrations of coproporphyrins, consisting of nearly 100% of the isomer I series, also excluded the diagnosis of hereditary coproporphyria in our patient (1, 2).
Concerning differential diagnosis, the laboratory investigations must be used to exclude other forms of porphyria, particularly any of the extremely rare cases of homozygous porphyria, as found in cutaneous hepatic porphyria and hereditary coproporphyria (1, 2) . This diagnosis was excluded by the normal values of uroporphyrinogen decarboxylase and coproporphyrinogen oxidase in both parents, together with protoporphyrinogen oxidase.
With respect to the pathogenesis of cutaneous lesions (major photosensitivity observed after phototherapy, applied in this case because of icterus), many of the features of congenital erythropoietic porphyria differ only in severity from those found in other cutaneous porphyrias, such as cutaneous hepatic porphyria (1, 2). Our patient shows moderate hirsutism, which is commonly observed in cases of congenital erythropoietic porphyria (1, 2).
The majority of the patients presenting congenital erythropoietic porphyria suffer from haemolytic anaemia (1, 2) . In this case, anaemia (haemoglobin concentration: 72 g/1) was diagnosed at 28 weeks and was treated by two in utero transfusions at 28 and 29 weeks. Indirect and direct Coomb's tests were negative. Haemolysis seems to be associated with an increased osmotic fragility of erythrocytes, due to increased concentrations of erythrocyte porphyrins (37) . Porphyrin deposition may also be found in bone marrow (38) , where between 30 and 70% of the erythroblasts show porphyrin fluorescence (fluorocytes), i.e. bright red fluorescence is observed under longwavelength UV light (38) ; this was also observed in our case.
The patient showed marked hepatosplenomegaly. In congenital erythropoietic porphyria, the liver in particular makes a significant contribution to excessive porphyrin synthesis (39) . Splenomegaly is always observed in cases of congenital erythropoietic porphyria (1, 2). There are no characteristic histological findings in the spleen other than the manifestations of haemolysis (1^2). .;
Congenital erythropoietic porphyria is expressed very rarely in utero, as is shown by the autopsy on a newborn child (40) , by diagnosis at birth (6) and by prenatal diagnosis (7, 8) . Reddish-brown amniotic fluid with an increased porphyrin content is usually encountered early in the second trimester of pregnancy in fetuses with congenital erythropoietic porphyria (7, 41) . In the present case, this fluid was colourless.
One of the earliest signs of the disease may be the excretion of reddish-coloured urine (1, 2). Emission of pink urine after three hours of life, together with a naso-pharyngal and gastric aspiration of pink liquid was observed in our case.
The patient shows the criteria of neonatal congenital erythropoietic porphyria, according to Schwartz:
1) emission of red urine together with an increase of uroporphyrins and coproporphyrins and normal concentrations of 5-aminolaevulinic acid and porphobilinogen;
2) presence of splenomegaly and haemolytic anaemia;
3) red fluorescence of the bone marrow (14) .
Clinically, congenital erythropoietic porphyria may be distinguished from early-onset cutaneous hepatic porphyria by the presence of splenomegaly, erythrodontia (due to porphyrin accumulation in teeth, pathognomonic of congenital erythropoietic porphyria), anaemia and erythrocyte fluorescence (1, 2).
Congenital erythropoietic porphyria is inherited in an autosomal recessive fashion (1, 2) . In this family, both parents are asymptomatic and heterozygous for congenital erythropoietic porphyria. Their first child was in good health. The second child died in utero at 33 weeks under very similar conditions to those observed in the present case (their third child): hydrops foetalis with hepatosplenomegaly compatible with an haemolytic anaemia (Coomb's test was negative) and extramedullar erythropoiesis.
The isolation and sequencing of a full-length complementary DNA (cDNA) encoding uroporphyrinogen III synthase allows the study of the enzymatic defect at the molecular level (42) . Different point mutations, insertions or deletions have been detected (43 -45) .
It has now been shown that one of the parents carries the C 73 R mutation (a cysteine replaced by an arginine at position 73 in the protein), which has been previously described (43) .
Conclusion
A fatal case of Günthers disease (congenital erythropoietic porphyria) is reported in a baby whose birth was induced at 32 weeks. The biochemical diagnosis was made on the basis of:
1. a massive increase, in erythrocytes, plasma, urine and faeces, of type-I porphyrins (mainly coproporphyrin);
2. a familial study revealing that both parents are heterozygous for uroporphyrinogen III synthase deficiency;
3. the observation of a point mutation in codon 73 in one parent.
Fatal cases of neonatal congenital erythropoietic porphyria are extremely rare and such an observation, according to our knowledge, is probably one of the first described.
